Document is current

Article History

Received: 6 February 2020

Accepted: 28 January 2021

First Online: 18 February 2021

Competing interests

: LG-B is a professor of clinical pharmacology at the University of Paris-Saclay. She was with the LASER group at the time of the study and is an active member of the PGRx Study Group. BB is an emeritus professor at the University of Bordeaux. He was on the scientific board of the study. JB has no potential conflict of interest to disclose. CN works as a consultant for the LA-SER group. OD is an employee of Laser Core Paris, a company specialized in conducting observational studies in pharmacoepidemiology, many financed by the pharmaceutical industry. NM is an employee of Laser Core Paris, a company specialized in conducting observational studies in pharmacoepidemiology, many financed by the pharmaceutical industry. YH is an employee of Laser Core Paris, a company specialized in conducting observational studies in pharmacoepidemiology, many financed by the pharmaceutical industry. YC is Head of the Cardiology Department of the University Hospital Dijon Bourgogne. He has speaker contracts with Pfizer, BMS, Novartis, Servier, Bayer. ES is a professor of Ear, Nose and Throat Therapy at the University of Paul Sabatier in Toulouse, France. He works as a freelance consultant and provides paid freelance consultation for laboratories: ALK, Stallergènes, Mylan Medical, Zambon, and Meda Pharma. LA is the founder and a member of the Laser Group, which conducts studies financed by multiple pharmaceutical companies. ET has served as assistant editor for the journal Stroke (AHA) since 2012, received honoraria from BMS, Pfizer, and Boehringer-Ingelheim before 2017, and declares no other potential conflict of interest since then.